Log In
Print
BCIQ
Print
Print this Print this
 

ALX-0171

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionNanobody against RSV F protein
Molecular Target RSV F protein
Mechanism of ActionBinds RSV F protein; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsTreat respiratory syncytial virus (RSV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today